Due to a rapid decline of protective anticoagulation with novel oral anticoagulants (NOACs)
when doses are omitted, a high degree medication adherence to NOACs is essential for …

BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used for
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …

BACKGROUND: Adherence to oral anticoagulant (OAC) agents is important for patients with
nonvalvular atrial fibrillation (NVAF) to prevent potentially severe adverse events …

BACKGROUND: Few studies have assessed adherence to non-vitamin K antagonist oral
anticoagulants (NOACs), especially using contemporary data now that multiple NOACs are …

A retrospective cohort analysis of the US MarketScan claims databases was performed to
compare persistence and discontinuation rates between the vitamin K antagonist warfarin …

Objectives: Our study examined the impact of adherence to novel oral anticoagulants
[NOACs-dabigatran and rivaroxaban] on ischemic-stroke (IS), major-bleeding (MB), deep …

Abstract Background Direct oral anticoagulants (DOACs) are widely used for stroke
prevention in patients with non-valvular atrial fibrillation (NVAF). We investigated the …

Purpose Non-vitamin K antagonist oral anticoagulant medications are increasingly used for
stroke prophylaxis in patients with nonvalvular atrial fibrillation (NVAF). This study aimed to …

Abstract Purpose Direct oral anticoagulants (DOACs) have been promoted in patients with
nonvalvular atrial fibrillation (nv‐AF) as a more convenient alternative to vitamin K …

Background Medication non-adherence can result in poor health outcomes. Understanding
differences in adherence rates to non-vitamin K oral anticoagulants (NOACs) could guide …